What is NDC 62135-677?

62135-677 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rasagiline?

26 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rasagiline NDC 62135-677 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-677Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0677Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-677-30	6213506773062135067730	30 TABLET in 1 BOTTLE (62135-677-30)Marketed from May 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasagiline
Generic name (nonproprietary): rasagiline
Active ingredients: Rasagiline mesylate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201892
Marketing start: Jul 27, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Monoamine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 62135-677_17dd92b2-969b-16f1-e063-6394a90aee89SPL ID 17dd92b2-969b-16f1-e063-6394a90aee89SPL set ID d9168d62-814a-444f-9d70-11674def339dRxCUI 608328, 636664UNII LH8C2JI290UPC 0362135677305, 0362135676308
Pharmacologic class: Monoamine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135067730 followed by a unit qualifier and the quantity

Package 62135-0677-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 7, 2024.

Indications (excerpt from the label)

Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline tablets, a monoamine oxidase (MAO)-B inhibitor (MAOI), are indicated for the treatment of Parkinson's disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-677

What is NDC 62135-677?: 62135-677 is the product NDC for Rasagiline, Rasagiline mesylate 1 mg/1 tablet, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rasagiline.
What is the active ingredient?: Rasagiline mesylate.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rasagiline?: 26 other product NDCs are listed under this name. See all Rasagiline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rasagiline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rasagiline	Rasagiline mesylate 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4735	70518-4735-0070518-4735-01
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4683	70518-4683-00
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-141	80005-0141-0880005-0141-1080005-0141-14
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Carnegie Pharmaceuticals LLC	80005-142	80005-0142-0880005-0142-1080005-0142-14
Rasagiline	Rasagiline mesylate 1 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-446	13668-0446-0513668-0446-3013668-0446-90
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Torrent Pharmaceuticals Limited	13668-447	13668-0447-0513668-0447-3013668-0447-90
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-711	64980-0711-30
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-712	64980-0712-30
Rasagilinerasagiline mesylate	Rasagiline mesylate .5 mg/1	TabletOral	SKG Pharma Inc.	83085-007	83085-0007-1083085-0007-3083085-0007-50
Rasagilinerasagiline mesylate	Rasagiline mesylate 1 mg/1	TabletOral	SKG Pharma Inc.	83085-008	83085-0008-1083085-0008-3083085-0008-50

All 27 Rasagiline NDCs

Other NDCs under ANDA 201892

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201892
Product	Strength	Form · route	Labeler	Product NDC
Rasagiline	Rasagiline mesylate .5 mg/1	TabletOral	Chartwell RX, LLC	62135-676